Coronavirus – Etiopatogenia y Genética – Artículos en inglés

Información actualizada al 28 de setiembre de 2020

• TÍTULO: Naturally activated adaptive immunity in COVID-19 patients.

AUTOR: Yang X, Dai T, Zhou X…[et all.]. 
J Cell Mol Med. 2020 sep 25. DOI: 10.1111/jcmm.15771

• TÍTULO: SARS-CoV-2 spreads to lymph nodes and strongly expands CD4+ TEMRA cells in a patient with mild COVID-19.

AUTOR:  Ernesto Roldán-Santiago, Amparo Benito-Berlinches, Laura Martínez-García…[et all.].
Clin Infect Dis. 2020 sep 18. DOI: 10.1093/cid/ciaa1422

• TÍTULO: Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19. 

AUTOR: Maia Norman, Tal Gilboa, Alana F Ogata…[et all.]. 
Nat Biomed Eng. 2020 sep 18. DOI: 10.1038/s41551-020-00611-x

• TÍTULO: Switching Host Metabolism as an Approach to Dampen SARS-CoV-2 Infection.

AUTOR: Sameh Soliman, MoezAlIslam E Faris, Zakaria Ratemi, Rabih Halwani. 
 Ann Nutr Metab. 2020 sep 18. DOI: 10.1159/000510508

• TÍTULO: Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection. 

AUTOR: Seltzer. 
Int J Infect Dis. 2020 sep 17. DOI: 10.1016/j.ijid.2020.09.041

• TÍTULO: Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach. 

AUTOR: Sorwer Alam Parvez, Adnan Karim, Mahmudul Hasan…[et all.]. 
Int J Biol Macromol. 2020 sep 17. DOI: 10.1016/j.ijbiomac.2020.09.098

• TÍTULO: Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development.

AUTOR: Kevin Ita. 
Arch Med Res. 2020 sep 10. DOI: 10.1016/j.arcmed.2020.09.010

• TÍTULO: Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19. 

AUTOR: Norman M, Gilboa T, Ogata AF… [et all.]. 
Nat Biomed Eng. 2020 sep 18. DOI: 10.1038/s41551-020-00611-x.

• TÍTULO: Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review. 

AUTOR: Otręba M, Kośmider L, Rzepecka-Stojko A. 
Eur J Pharmacol. 2020 sep 16. DOI: 10.1016/j.ejphar.2020.173553

• TÍTULO: Sequence characterization and molecular modeling of clinically relevant variants of the SARS-CoV-2 main protease.

AUTOR: Thomas J Cross, Gemma R Takahashi, Elizabeth M Diessner…[et all.].
Biochemistry. 2020 sep 15. DOI: 10.1021/acs.biochem.0c00462

• TÍTULO: SAR of novel benzamides and isoindolines, designed as SARS‐CoV protease inhibitors – effective against SARS‐CoV‐2. 

AUTOR: Armin Welker, Christian Kersten, Christin Müller…[et all.].
ChemMedChem. 2020 sep 15. DOI: 10.1002/cmdc.202000548

• TÍTULO: Naltrexone a potential therapeutic candidate for COVID-19.

AUTOR: Abhinav Choubey, Budheswar Dehury, Sunil Kumar, Bikash Medhi, Prosenjit Mondal.
J Biomol Struct Dyn. 2020 sep 15. DOI: 10.1080/07391102.2020.1820379

• TÍTULO: Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral–bacterial interactions. 

AUTOR: Ilja L Kruglikov, Manasi Shah, Philipp E Scherer.
Elife. 2020 sep 15. DOI: 10.7554/eLife.61330

• TÍTULO: Cytokine release syndrome in COVID‐19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.

AUTOR: Aaron C Petrey, Fares Qeadan, Elizabeth A Middleton…[et all.].
J Leukoc Biol. 2020 sep 15. DOI: 10.1002/JLB.3COVA0820-410RRR

• TÍTULO: Prospects for mucosal vaccine: shutting the door on SARS-CoV-2. 

AUTOR: Rajat Mudgal, Sanketkumar Nehul, Shailly Tomar.
Hum Vaccin Immunother. 2020 sep 20. DOI: 10.1080/21645515.2020.1805992

• TÍTULO:  Angioedema, ACE inhibitor and COVID-19.

AUTOR: Ekjot Grewal, Bayu Sutarjono, Ibbad Mohammed.  
BMJ Case Rep. 2020 sep 11. DOI: 10.1136/bcr-2020-237888

• TÍTULO: COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence?. 

AUTOR: Diogo Goulart Corrêa, Fabiana Cavalcanti de Souza Lima, Daniel da Cruz Bezerra.
Mult Scler. 2020 sep 10. DOI: 10.1177/1352458520949988

• TÍTULO: Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses. 

AUTOR: Abdus Samad, Tamanna Jafar, Jahirul Hasnat Rafi.
Genomics. 2020 nov. DOI:10.1016/j.ygeno.2020.09.002

• TÍTULO: Computational immune proteomics approach to target COVID-19. 

AUTOR: Bruno Tilocca, Domenico Britti, Andrea Urbani… [et all.]. 
J. Proteome Res. 2020 sep 11. DOI: 10.1021/acs.jproteome.0c00553

• TÍTULO: A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection 

AUTOR: Megan C. Sharps, Dexter J.L. Hayes, Stacey Lee… [et all.].  
Placenta. 2020 nov. DOI: 10.1016/j.placenta.2020.08.018

• TÍTULO: The kinetics of viral load and antibodiesto SARS-CoV-2. 

AUTOR: Sun J, Tang X, Bai R…  [et all].  
Clin Microbiol Infect. 2020 sep 5. DOI:10.1016/j.cmi.2020.08.043

• TÍTULO: Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in market in 2020. 

AUTOR: Beijing's Xinfadi, Zhang Y, Pan Y, Zhao X… [et all].
Biosaf Health. 2020 sep 2 . DOI:10.1016/j.bsheal.2020.08.006

• TÍTULO: Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing’s Xinfadi market in 2020.

AUTOR: Yong Zhang, Yang Pan, Xiang Zhao…[et all.].
Biosaf Health. 2020 sep 2. DOI: 10.1016/j.bsheal.2020.08.006

• TÍTULO: Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.

AUTOR: Qinhai Ma, Runfeng Li, Weiqi Pan…[et all.].
Phytomedicine. 2020 nov. DOI: 10.1016/j.phymed.2020.153296

• TÍTULO: Drug repurposing approach to fight COVID-19.

AUTOR: Thakur Uttam Singh, Subhashree Parida, Madhu Cholenahalli Lingaraju…[et all.].
Pharmacol Rep. 2020 sep 5. DOI: 10.1007/s43440-020-00155-6

• TÍTULO: Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19.

AUTOR: Seshadri Reddy Varikasuvu, Saurabh Varshney, Naveen Dutt.
J Thromb Thrombolysis. 2020 sep 5. DOI: 10.1007/s11239-020-02270-w

• TÍTULO: Predicted peptide patterns from the SARS-CoV-2 proteome for MS-MS based diagnosis.

AUTOR: Saketh Kapoor, Pratigya Subba.
J Biomed Inform. 2020. DOI: 10.6026/97320630016477

• TÍTULO: Antibody response and the clinical presentation of patients with COVID-19 in Croatia: the importance of a two-step testing approach.

AUTOR: Oktavija Đaković Rode, Ivan-Christian Kurolt, Ivan Puljiz, Rok Čivljak… [et all.].
Eur J Clin Microbiol Infect Dis. 2020 sep 04. DOI: 10.1007/s10096-020-04019-y

• TÍTULO: COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm. 

AUTOR: Wonhwa Lee, June Hong Ahn, Hee Ho Park… [et all.]. 
Signal Transduct Target Ther. 2020 sep 03. DOI: 10.1038/s41392-020-00292-7

• TÍTULO: Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.

AUTOR: Muchtaridi Muchtaridi, OrcID,M. Fauzi, Nur Kusaira Khairul Ikram… [et all.].
Molecules. 2020 aug. DOI: 10.3390/molecules25173980

•  TÍTULO:Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics.

AUTOR: Jonathan Baruch Steinman, Fok Moon Lum, Peggy Pui-Kay Ho… [et all.].
Proc. Natl. Acad. Sci. 2020 sep 3. DOI: 10.1073/pnas.2012358117

• TÍTULO: Managing the COVID-19 Pandemic: Research Strategies Based on the Evolutionary and Molecular Characteristics of Coronaviruses. 

AUTOR: Sabhiya Majid, Rabia Farooq, Mosin S Khan…[et all.].
SN Compr Clin Med. 2020 aug 25. DOI: 10.1007/s42399-020-00457-z

• TÍTULO: Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies.

AUTOR: Domenico Luca Grieco, Filippo Bongiovanni , Lu Chen …[et all.].
Crit Care. 2020 aug 28. DOI: 10.1186/s13054-020-03253-2

• TÍTULO: The receptor binding domain of SARS-CoV-2 spike protein is the result of an ancestral recombination between the bat-CoV RaTG13 and the pangolin-CoV MP789.

AUTOR: Alejandro Flores-Alanis, Luisa Sandner-Miranda, Gabriela Delgado, Alejandro Cravioto, Rosario Morales-Espinosa. 
BMC Res Notes. 2020 aug 27. DOI: 10.1186/s13104-020-05242-8

• TÍTULO: Does phenotypic expression of bitter taste receptor T2R38 show association with COVID‐19 severity?.

AUTOR: Henry P Barham, Mohamed A Taha, Christian A Hall.
Int Forum Allergy Rhinol. 2020 aug 27. DOI: 10.1002/alr.22692

• TÍTULO:  Marked factor V activity elevation in severe COVID-19 is associated with venous thromboembolism. 

AUTOR:  Jonathan Stefely, Bianca Christensen, Tasos Gogakos.
Am. J. Hematol.2020 aug 24. DOI: 10.1002/ajh.25979.

• TÍTULO: Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays.

AUTOR: Fleur Wofff, Hafid Dhama, Cecile Duterme…  [et all]. 
M. Infec. Dis.2020.DOI: 10.1016/j.diagmicrobio.2020.115140.

• TÍTULO: Laser irradiated phenothiazines: New potential treatment for COVID-19 explored by molecular docking.

AUTOR: Ana Maria Udrea, Speranta Avram, Simona Nistorescu… [et all.]. 
Photochem. Photobiol.2020 oct. DOI: 10.1016/j.jphotobiol.2020.111997

• TÍTULO: Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2. 

AUTOR: David J. Huggins.
Mol. Graph. Model. 2020. DOI: 10.1016/j.jmgm.2020.107710

• TÍTULO: The use of knowledge management tools in viroinformatics. Example study of a highly conserved sequence motif in Nsp3 of SARS-CoV-2 as a therapeutic target.

AUTOR: B. Robson.
Comput. Biol. Med.2020. DOI: 10.1016/j.compbiomed.2020.103963

• TÍTULO: Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease.

AUTOR: Qingxin Li , CongBao Kang.
Microorganisms.2020 aug 18. DOI: 10.3390/microorganisms8081250

• TÍTULO: COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy.

AUTOR: Sabyasachi Chatterjee, Tanusree Sengupta, Samarpan Majumder …[et all.]. 
Aging (Albany NY). 2020. DOI: 10.18632/aging.103869

• TÍTULO: Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein.

AUTOR: Daniella S Battagello, Guilherme Dragunas, Marianne O Klein…[et all.].
Comput. Biol. Med.2020.  DOI:10.1016/j.compbiomed.2020.103967

• TÍTULO:  A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases.

AUTOR: Peng Xia, Yubing Wen, Yaqi Duan…et all].
J Am Soc Nephrol. 2020 dic. DOI: 10.1681/ASN.2020040426

• TÍTULO: Natural killer cell immunotypes related to COVID-19 disease severity.

AUTOR: Christopher Maucourant, Iva Filipovic, Andrea Ponzetta…[et all.].
Sci Immunol. 2020 aug 21. DOI: 10.1126/sciimmunol.abd6832

• TÍTULO: An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques.

AUTOR: Liqiang Feng, Qian Wang, Chao Shan…[et all].
Nat Commun. 2020 aug 21. DOI: 10.1038/s41467-020-18077-5

• TÍTULO: Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission.

AUTOR: Daniella S Battagello, Guilherme Dragunas, Marianne O Klein…[et all.].
Clin Sci (Lond). 2020 aug 21. DOI: 10.1042/CS20200904

• TÍTULO: The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients.

AUTOR: Alessandro Marcello, Andrea Civra, Rafaela Milan Bonotto.
Redox Biol. 2020 set. DOI: 10.1016/j.redox.2020.101682

• TÍTULO: Oxytocin’s Anti-inflammatory and Pro-immune functions in COVID-19: A Transcriptomic Signature Based Approach.

AUTOR: Ali S Imami, Sinead M O'Donovan, Justin F Creeden…[et all.].
Physiol Genomics. 2020 aug 18. DOI: 10.1152/physiolgenomics.00095.2020

• TÍTULO: Integrative Modelling of Quantitative Plasma Lipoprotein, Metabolic and Amino Acid Data Reveals a Multi-organ Pathological Signature of SARS-CoV-2 Infection.

AUTOR: Torben Kimhofer, Samantha Lodge, Luke Whiley…[et all.].
J Proteome Res. 2020 aug 17. DOI: 10.1021/acs.jproteome.0c00519

• TÍTULO: Potential Leads from Liquorice against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies.

AUTOR: Saurabh K Sinha, Satyendra K Prasad, Md Ataul Islam, Sushil K Chaudhary, Shashikant 
Singh, Anshul Shakya.
Comb Chem High Throughput Screen. 2020 aug 16. DOI: 10.2174/1386207323999200817103148

• TÍTULO: Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients.

AUTOR: Ignacio Iturrieta-Zuazo, Claudia Geraldine Rita, Ana García-Soidán…[et all.].
Clin Immunol. 2020 aug 15. DOI: 10.1016/j.clim.2020.108572

• TÍTULO: Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics.

AUTOR: Andreas Ritter, Nina-Naomi Kreis, Frank Louwen, Juping Yuan.
Int J Mol Sci. 2020 aug 12. DOI: 10.3390/ijms21165793

• TÍTULO: Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.

AUTOR: Robert W Körner, Mohamed Majjouti, Miguel A Alejandre Alcazarx0078, Esther Mahabir.
Viruses. 2020 aug 12. DOI: 10.3390/v12080880

• TÍTULO: Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.

AUTOR: Baofu Qiao, Monica Olvera de la Cruz. 
ACS Nano. 2020 aug 4. DOI: 10.1021/acsnano.0c04798

• TÍTULO: Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments.

AUTOR: Pedram Goodarzi, Farzad Mahdavi, Rasoul Mirzaei.
Int Immunopharmacol. 2020 nov. DOI: 10.1016/j.intimp.2020.106885

• TÍTULO: Mitochondrial-targeted ubiquinone: A potential treatment for COVID-19.

AUTOR: Lichen Ouyang, Jie Gong.
Med Hypotheses. 2020 nov. DOI: 10.1016/j.mehy.2020.110161

• TÍTULO: Is there a role for insulin-like growth factor inhibition in the treatment of COVID-19-related adult respiratory distress syndrome?.

AUTOR: Bryan J. Winn.
Med Hypotheses. 2020 nov. DOI: 10.1016/j.mehy.2020.110167

• TÍTULO: Autoimmunity to ACE2 as a possible cause of tissue inflammation in Covid-19. 

AUTOR: Alain Townsend.
Med Hypotheses. 2020 nov. DOI: 10.1016/j.mehy.2020.110043

• TÍTULO: Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.

AUTOR: Marianno Franzinia, Luigi Valdenassi, Giovanni Ricevuti…[et all.].
Int Immunopharmacology. 2020 nov. DOI: 10.1016/j.intimp.2020.106879

• TÍTULO: Plasma from recovered COVID-19 subjects inhibits spike protein binding to ACE2 in a microsphere-based inhibition assay.

AUTOR: Edward P Gniffke, Whitney E Harrington, Nicholas Dambrauskas…[et all].
J Infect Dis. 2020 agu 15. DOI: 10.1093/infdis/jiaa508

• TÍTULO: Anatomical and timely assessment of protein expression of angiotensin‐converting enzyme 2, SARS‐CoV‐2 specific receptor, in fetal and placental tissues: new insight for perinatal counseling.

AUTOR: V Faure-Bardon, P Isnard, N Roux, M Leruez-Ville, T Molina, B Bessieres, Y Ville.
Ultrasound Obstet Gynecol. 2020 aug 15. DOI: 10.1002/uog.22178

• TÍTULO: Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.

AUTOR: Fan Zhang, Rui Gan, Ziqi Zhen…[et all.].
Signal Transduct Target Ther. 2020 aug 14. DOI: 10.1038/s41392-020-00263-y

• TÍTULO: A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality.

AUTOR: Lucinda Smart, Neil Fawkes, Paul Goggin…[et all.].
Inflammopharmacology. 2020 aug 14. DOI: 10.1007/s10787-020-00745-z

• TÍTULO: A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge.

AUTOR: Shipo Wu, Gongxun Zhong, Jun Zhang…[et all.].
Nat Commun. 2020 aug 14. DOI: 10.1038/s41467-020-17972-1

• TÍTULO: Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications on COVID-19 immunity.

AUTOR: Kathleen M McAndrews, Dara P Dowlatshahi, Jianli Dai…[et all.].
JCI Insight. 2020 aug 14. DOI: 10.1172/jci.insight.142386

• TÍTULO: The potential involvement of P2X7 receptor in COVID‐19 pathogenesis: a new therapeutic target?.

AUTOR: Paulo A F Pacheco, Robson X Faria.
Scand J Immunol. 2020 aug 14. DOI: 10.1111/sji.12960

• TÍTULO: Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (Mpro) through docking, molecular mechanic & dynamic, and ADMET profiling.

AUTOR: Karina Kapusta, Supratik Kar, Jasmine T Collins…[et all.].
J Biomol Struct Dyn. 2020 aug 14. DOI: 10.1080/07391102.2020.1806930

• TÍTULO: Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.

AUTOR: Ali Akbari, Jafar Rezaie.
Stem Cell Res Ther. 2020 aug 14. DOI: 10.1186/s13287-020-01866-6

• TÍTULO: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. 

AUTOR: Antonio E Muruato, Camila R Fontes-Garfias, Ping Ren, Mariano A Garcia-Blanco…[et all.].
Nat Commun. 2020 aug 13. DOI: 10.1038/s41467-020-17892-0

• TÍTULO: Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.

AUTOR: Asaf Poran, Dewi Harjanto, Matthew Malloy…[et all.].
Genome Med. 2020 aug 13. DOI: 10.1186/s13073-020-00767-w

• TÍTULO: Global cataloguing of variations in untranslated regions of viral genome.

AUTOR: Moumita Mukherjee, Srikanta Goswami.
PLoS One. 2020 aug 11. DOI: 10.1371/journal.pone.0237559

• TÍTULO: Mutational spectra of SARS‐CoV‐2 orf1ab polyprotein and signature mutations in the United States of America.

AUTOR: Shuvam Banerjee, Sohan Seal, Riju Dey, Kousik Kr Mondal, Pritha Bhattacharjee.
J Med Virol. 2020 aug 11. DOI: 10.1002/jmv.26417

• TÍTULO: A human circulating immune cell landscape in aging and COVID-19.

AUTOR: Yingfeng Zheng, Xiuxing Liu, Wenqing Le…[et all.].
Protein Cell. 2020 aug 11. DOI: 10.1007/s13238-020-00762-2

• TÍTULO: Angiotensin-converting Enzyme 2 roles in the Pathogenesis of COVID-19.

AUTOR: Azra Kenarkoohi, Maryam Maleki, Tahereh Safari, Mohamadreza Kafashian, Fateme Saljoughi, Shahla Sohrabipour.
Curr Hypertens Rev. 2020 aug 10. DOI: 10.2174/1573402116666200810134702

• TÍTULO: A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection.

AUTOR: Pablo Cruces, Jaime Retamal, Daniel E Hurtado…[et all.].
Crit Care. 2020 aug 10. DOI: 10.1186/s13054-020-03197-7 

• TÍTULO: Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6.

AUTOR: Jie Zhao, Xiaodong Yang, Chenghua Wang…[et all.].
Biomed Pharmacother. 2020 set. DOI: 10.1016/j.biopha.2020.110436

• TÍTULO: Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients.

AUTOR: Ya-Qi Duan, Ming-Hui Xia, Liang Ren…[et all.].
Curr Med Sci. 2020 aug 7. DOI: 10.1007/s11596-020-2225-x

• TÍTULO: Favipiravir may acts as covid-19 main protease pdb id 6lu7 inhibitor: Docking análisis.

AUTOR: Ajeet Aggarwal, Babita Verma,  Santosh Kumar.
Biointerface Res Appl Chem. 2020 dec. DOI: 10.33263/BRIAC106.68216828

• TÍTULO: Inhibition of SARS-CoV-2 main protease 3CLpro by means of α-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking.

AUTOR: Amin O. Elzupir.
J Mol Structures. 2020 dec. DOI: 10.1016/j.molstruc.2020.128878

• TÍTULO: COVID-19 exposures and infection control among home care agencies.

AUTOR: Theresa A Rowe, Mallika Patel, Rachel O'Conor, Sheila McMackin, Vicki Hoak, Lee A Lindquist. 
Arch Gerontol Geriatr. 2020 nov-dec. DOI: 10.1016/j.archger.2020.104214

• TÍTULO: Crystal structure, chemical reactivity, kinetic and thermodynamic studies of new ligand derived from 4-hydroxycoumarin: Interaction with SARS-CoV-2.

AUTOR: Chafia Ait-Ramdane-Terbouche, Hasnia Abdeldjebar, Achour Terbouche.
J Mol Struct. 2020 dec. DOI: 10.1016/j.molstruc.2020.128918

• TÍTULO: Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions.

AUTOR: Nikhil Sangith.
Med Hypotheses. 2020 nov. DOI: 10.1016/j.mehy.2020.110030

• TÍTULO: Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections.

AUTOR: Giampaolo Minetti.
Med Hypotheses. 2020 nov. DOI: 10.1016/j.mehy.2020.110128

• TÍTULO: COVID-19: NAD+ deficiency may predispose the aged, obese and type2 diabetics to mortality through its effect on SIRT1 activity.

AUTOR: R Miller, A R Wentzel, G A Richards.
Med Hypotheses. 2020 nov. DOI: 10.1016/j.mehy.2020.110044

• TÍTULO: SARS-CoV-2 and the sympathetic immune response: Dampening inflammation with antihypertensive drugs (Clonidine and Propranolol).

AUTOR: Sanjiv K Hyoju, Olga Zaborina, Harry van Goor.
Med Hypotheses. 2020 nov. DOI: 10.1016/j.mehy.2020.110039

• TÍTULO: COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.

AUTOR: Rosemary Gan, Nicholas P Rosoman, David J E Henshaw, Euan P Noble, Peter Georgius, Nigel 
Sommerfeld.
Med Hypotheses. 2020 nov. DOI: 10.1016/j.mehy.2020.110024

• TÍTULO: Ibuprofen, a traditional drug that may impact the course of COVID-19 new effective formulation in nebulizable solution.

AUTOR: Néstor H García, Daniela J Porta, Roxana V Alasino, Sonia E Muñoz, Dante M Beltramo.
Med Hypotheses. 2020 nov. DOI: 10.1016/j.mehy.2020.110079

• TÍTULO: Estrogen shields women from COVID-19 complications by reducing ER stress.

AUTOR: Sana Shabbir, Assad Hafeez, Muhammad Arshad Rafiq, Muhammad Jawad Khan.
Med Hypotheses. 2020 oct. DOI: 10.1016/j.mehy.2020.110148

• TÍTULO: Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy. 

AUTOR: Leo Nicolai, Alexander Leunig, Sophia Brambs…[et all.].
Circulation. 2020 aug 10. DOI: 10.1161/CIRCULATIONAHA.120.048488

• TÍTULO: SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.

AUTOR: Rafal Bartoszewski, Michal Dabrowski, Bogdan Jakiela…[[et all.].
Am J Physiol Lung Cell Mol Physiol. 2020 aug 8. DOI: 10.1152/ajplung.00252.2020

• TÍTULO: Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.

AUTOR: Panagiotis Skendros, Alexandros Mitsios, Akrivi Chrysanthopoulou…[et all.].
J Clin Invest. 2020 aug 6. DOI: 10.1172/JCI141374

• TÍTULO: Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population.

AUTOR: Ronald Rodrigues de Moura, Almerinda Agrelli, Carlos André Santos-Silva…[et all.].
J Clin Pathol. 2020 aug 5. DOI: 10.1136/jclinpath-2020-206946

• TÍTULO: Rewiring the Immune Response in COVID-19.

AUTOR: James D Chalmers, Sanjay H Chotirmall.
Am J Respir Crit Care Med. 2020 aug 5. DOI: 10.1164/rccm.202007-2934ED

• TÍTULO: Smoking and COVID ‐19: Similar bronchial ACE2 and TMPRSS2 expression and higher TMPRSS4 expression in current versus never smokers.

AUTOR: Irena Voinsky, David Gurwitz.
Drug Dev Res. 2020 aug 5. DOI: 10.1002/ddr.21729

• TÍTULO: Guillain Barré Syndrome associated with SARS‐CoV‐2 infection. A Systematic Review.

AUTOR: Paolo De Sanctis, Pietro Emiliano Doneddu, Luca Viganò, Carlo Selmi, Eduardo Nobile-Orazio.
Eur J Neurol. 2020 aug 5. DOI: 10.1111/ene.14462

• TÍTULO: ACE2 isoform diversity predicts the host susceptibility of SARS‐CoV‐2.

AUTOR: Shan Gao, Junwen Luan, Haoran Cui, Leiliang Zhang.
Transbound Emerg Dis. 2020 aug 5. DOI: 10.1111/tbed.13773

• TÍTULO: COVID-19: The Immune Responses and Clinical Therapy Candidates.

AUTOR: Sareh Zhand, Marie Saghaeian Jazi, Saeed Mohammadi…[et all.].
Int J Mol Sci. 2020 aug 3. DOI: 10.3390/ijms21155559

• TÍTULO: Mechanisms in endocrinology: vitamin d and COVID-19.

AUTOR: John P Bilezikian, Daniel Bikle, Martin Hewison.
Eur J Endocrinol. 2020 aug 1. DOI: 10.1530/EJE-20-0665

• TÍTULO: Pathogenesis of COVID-19-induced ARDS: implications for an aging population.

AUTOR: Manuel A Torres Acosta, Benjamin D Singer.
Eur Respir J. 2020 aug 3. DOI: 10.1183/13993003.02049-2020

• TÍTULO: SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.

AUTOR: Nele Wellinghausen, Dietmar Plonné, Meike Voss…[et all.].
J Clin Virol. 2020 set. DOI: 10.1016/j.jcv.2020.104542

• TÍTULO: Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection.

AUTOR: Kai Wang, Quan-Xin Long, Hai-Jun Deng…[et all.].
Clin Infect Dis. 2020 aug 3. DOI: 10.1093/cid/ciaa1143

• TÍTULO: Vascular occlusion by neutrophil extracellular traps in COVID-19.  

AUTOR: Moritz Leppkes, Jasmin Knopf, Elisabeth Naschberger…[et all.].
EBioMedicine. 2020 jul 31. DOI: 10.1016/j.ebiom.2020.102925

• TÍTULO: Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment.

AUTOR: Kerem Teralı, Buket Baddal, Hayrettin Ozan Gülcan.
J Mol Graph Model. 2020 nov. DOI: 10.1016/j.jmgm.2020.107697

• TÍTULO: Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications.

AUTOR: Francesco Barillà, Pier Paolo Bassareo, Giuseppe Calcaterra, Francesco Romeo, Jawahar L Mehta.
J Cardiovasc Med (Hagerstown). 2020 set. DOI: 10.2459/JCM.0000000000001071

• TÍTULO: The SARS-CoV-2 main protease as drug target.

AUTOR: Sven Ullrich, Christoph Nitsche.
Bioorg Med Chem Lett. 2020 set. DOI: 10.1016/j.bmcl.2020.127377

• TÍTULO: ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic.

AUTOR: Maya Braun, Elad Sharon, Irene Unterman…[et all.].
iScience. 2020 aug 21. DOI: 10.1016/j.isci.2020.101384

• TÍTULO: Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.

AUTOR: Gayathri Krishna, Vinod Soman Pillai, Mohanan Valiya Veettil.
Eur J Pharmacol. 2020 jul 31. DOI: 10.1016/j.ejphar.2020.173450

• TÍTULO: IgGs drive COVID-19 myeloid hyperinflammation.

AUTOR: Matthew D Park.
Nat Rev Immunol. 2020 jul 31. DOI: 10.1038/s41577-020-00415-9

• TÍTULO: Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient.

AUTOR: Daming Zhou, Helen M E Duyvesteyn, Cheng-Pin Chen…[et all.].
Nat Struct Mol Biol. 2020 jul 31. DOI: 10.1038/s41594-020-0480-y

• TÍTULO: Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases.

AUTOR: Giovanni A Rossi, Oliviero Sacco, Enrica Mancino, Luca Cristiani, Fabio Midulla.
Infection. 2020 jul 31. DOI: 10.1007/s15010-020-01486-5

• TÍTULO: Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach.

AUTOR: Ashish M Kanhed, Dushyant V Patel, Divya M Teli, Nirav R Patel, Mahesh T Chhabria, Mange Ram Yadav.
Mol Divers. 2020 jul 31. DOI: 10.1007/s11030-020-10130-1

• TÍTULO: The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro.

AUTOR: Mika Okamoto, Masaaki Toyama, Masanori Baba.
Antiviral Res. 2020 jul 31. DOI: 10.1016/j.antiviral.2020.104902

• TÍTULO: In silico Study of Azithromycin, Chloroquine and Hydroxychloroquine and their Potential Mechanisms of Action against SARS-CoV-2 Infection.

AUTOR: Helyson Lucas Bezerra Braz, João Alison de Moraes Silveira, Aline Diogo Marinho…[et all.].

Int J Antimicrob Agents. 2020 jul 29. DOI: 10.1016/j.ijantimicag.2020.106119

• TÍTULO: The African-American population with a low allele frequency of SNP rs1990760 (T allele) in IFIH1 predicts less IFN-beta expression and potential vulnerability to COVID-19 infection.

AUTOR: Amit K. Maiti.
Springer Link. 2020. jul 31. DOI: 10.1007/s00251-020-01174-6

• TÍTULO: Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe.

AUTOR: Umberto Malapelle, Pasquale Pisapia, Antonino Iaccarino…[et all.].
J Clin Pathol. 2020 jul 31. DOI: 10.1136/jclinpath-2020-206957

• TÍTULO: The ongoing COVID-19 epidemic in Minas Gerais, Brazil: insights from epidemiological data and SARS-CoV-2 whole genome sequencing.

AUTOR: Joilson Xavier, Marta Giovanetti, Talita Adelino…[et all.].
Emerg Microbes Infect. 2020 jul 29. DOI: 10.1080/22221751.2020.1803146

• TÍTULO: The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.

AUTOR: Franco Scaldaferri, Gianluca Ianiro, Giuseppe Privitera, …[et all.].
Inflammatory Bowel Diseases. 2020 jul 28. DOI: 10.1093/ibd/izaa181

• TÍTULO: Analysis of ACE2 Gene-Encoded Proteins Across Mammalian Species. 

AUTOR: Ying Cao, Yeping Sun, Xiaodong Tian, …[et all.].
Front. Vet. Sci. 2020 jul 03. DOI: 10.3389/fvets.2020.00457

• TÍTULO: SARS-CoV-2 detection in different respiratory sites: A systematic review and meta-analysis.

AUTOR: Abbas Mohammadi, Elmira Esmaeilzadeh, Yijia Li, …[et all.].
The Lancet. 2020 jul 24. DOI: 10.1016/j.ebiom.2020.102903

• TÍTULO: Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.

AUTOR: Shruti Ahlawat, Asha 1, Krishna Kant Sharma.
Virus Res. 2020 jul 24. DOI: 10.1016/j.virusres.2020.198103

• TÍTULO: Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2.

AUTOR: Li-Xia Zhang, Shu-Yan Miao, Zhong-Hua Qin…[et all.].
Mol Diagn Ther. 2020 jul 24. DOI: 10.1007/s40291-020-00486-3

• TÍTULO: Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients.

AUTOR: Lorenzo M Canziani, Serena Trovati, Enrico Brunetta…[et all.].
J Autoimmun. 2020 jul 08. DOI: 10.1016/j.jaut.2020.102511

• TÍTULO: Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes.

AUTOR: Hua Guo, Bing-Jie Hu, Xing-Lou Yang…[et all.].
J Virol. 2020 jul 22. DOI: 10.1128/JVI.00902-20

• TÍTULO: Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.

AUTOR:  Alireza Paniri, Haleh Akhavan-Niaki.
Life Sci. 2020 set. DOI: 10.1016/j.lfs.2020.118114

• TÍTULO: Potential Repurposed Therapeutics and New Vaccines against COVID-19 and Their Clinical Status.

AUTOR:  Abid H Banday, Shameem A Shameem, Sheikh J Ajaz.
SLAS Discov. 2020 jul 21. DOI: 10.1177/2472555220945281

•  TÍTULO: COVID-19 Docking Server: A meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19.

 AUTOR: Ren Kong, Guangbo Yang, Rui Xue, Ming Liu, Feng Wang, Jianping Hu, Xiaoqiang Guo, Shan Chang
Bioinformatics. 2020 jul 21. DOI: 10.1093/bioinformatics/btaa645

• TÍTULO: Cyanobacterial metabolites as promising drug leads against the Mpro and PLpro of SARS-CoV-2: an in silico analysis.

AUTOR:  Devashan Naidoo, Ayan Roy, Pallab Kar, Taurai Mutanda, Akash Anandraj.
J Biomol Struct Dyn. 2020 jul 21. DOI: 10.1080/07391102.2020.1794972

• TÍTULO: Stem cell therapies for COVID‐19: Strategy and application.

AUTOR:  Radbod Darabi, Yong Li.
J Cell Biochem. 2020 jul 21. DOI: 10.1002/jcb.29816

• TÍTULO: Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.

AUTOR:  Sofia Appelberg, Soham Gupta, Sara Svensson Akusjärvi…[et all.].
Emerg Microbes Infect. 2020 jul 21. DOI: 10.1080/22221751.2020.1799723

• TÍTULO: Model‐Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID‐19. 

AUTOR:  Michael G Dodds, Rajesh Krishna, Antonio Goncalves, Craig R Rayner.
Br J Clin Pharmacol. 2020 jul 21. DOI: 10.1111/bcp.14486

• TÍTULO:Lung protection by cathepsin C inhibition: a new hope for COVID-19 and ARDS?.

AUTOR:  Brice Korkmaz, Adam Lesner, Sylvain Marchand-Adam, Celia Moss, Dieter Erich Jenne.
J Med Chem. 2020 jul 21. DOI: 10.1021/acs.jmedchem.0c00776

• TÍTULO: Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis.

AUTOR:  Priyanka Sharma, Asifkhan Shanavas.
J Biomol Struct Dyn. 2020 jul 21. DOI: 10.1080/07391102.2020.1794970

• TÍTULO: Immune Responses to the Novel Coronavirus-2: Friend or Foe?.

AUTOR:  Ata Mahmoodpoor, Nader D Nader.
Immunol Invest. 2020 jul 21. DOI: 10.1080/08820139.2020.1795191

• TÍTULO: Virtual screening, molecular dynamics and structure–activity relationship studies to identify potent approved drugs for Covid-19 treatment. 

AUTOR:  Md Mahbubur Rahman, Titon Saha, Kazi Jahidul Islam…[et all.].
J Biomol Struct Dyn. 2020 jul 21. DOI: 10.1080/07391102.2020.1794974

• TÍTULO: Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19.

AUTOR:  Ying X Gue, Diana A Gorog…[et all.]
Eur Heart J. 2020 jul 20. DOI: 10.1093/eurheartj/ehaa534

• TÍTULO: An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates.

AUTOR:  Jesse H Erasmus, Amit P Khandhar, Megan A O'Connor.
Sci Transl Med. 2020 jul 20. DOI: 10.1126/scitranslmed.abc9396

• TÍTULO: A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.

AUTOR: Pedro F N Souza, Francisco E S Lopes, Jackson L Amaral, Cleverson D T Freitas, Jose T A Oliveira.
Int J Biol Macromol. 2020 dic. DOI: 10.1016/j.ijbiomac.2020.07.174

• TÍTULO: SARS‐CoV‐2 S1 is superior to the RBD as a COVID‐19 subunit vaccine antigen.

AUTOR: Yunfei Wang, Lichun Wang, Han Cao, Cunbao Liu.
J Med Virol. 2020 jul 21. DOI: 10.1002/jmv.26320

• TÍTULO: Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19.

AUTOR: Minchen Chien, Thomas K Anderson, Steffen Jockusch…[et all.].
J Proteome Res. 2020 jul 21. DOI: 10.1021/acs.jproteome.0c00392

• TÍTULO: SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.

AUTOR: Daniel M Altmann, Rosemary J Boyton.
Sci Immunol. 2020 jul 17. DOI: 10.1126/sciimmunol.abd6160

• TÍTULO: Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.

AUTOR: Matthias Thoms, Robert Buschauer, Michael Ameismeier…[et all.].
Science. 2020 jul 17. DOI: 10.1126/science.abc8665

• TÍTULO: Comprehensive Review on Current Interventions, Diagnostic, and Nanotechnology Perspectives against SARS-CoV-2.

AUTOR: Deepak S Chauhan, Rajendra Prasad, Rohit Srivastava, Meena Jaggi, Subhash C Chauhan, 
Murali M Yallapu.
Bioconjug Chem. 2020 jul 17. DOI: 10.1021/acs.bioconjchem.0c00323

• TÍTULO: Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.

AUTOR: Xiaoyi Fan, Duanfang Cao, Lingfei Kong, Xinzheng Zhang.
Nat Commun. 2020 jul 17. DOI: 10.1038/s41467-020-17371-6

• TÍTULO: Immuno-pathogenesis of nCOVID-19 and a possible host-directed therapy including anti-inflammatory and anti-viral prostaglandin (PG J2) for effective treatment and reduction in the death toll. 

AUTOR: Shahzad S, Willcox M
Med Hypotheses. 2020 oct.  DOI: 10.1016/j.mehy.2020.110080

• TÍTULO: Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review. 

AUTOR: Zahra Noorimotlagh, Chiman Karami, Seyyed Abbas Mirzaee…[et all.].
Int Immunopharmacol. 2020 set. DOI: 10.1016/j.intimp.2020.106738

• TÍTULO: ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosis.

AUTOR: Sofia D Viana, Sara Nunes, Flávio Reis.
Ageing Res Rev. 2020 set – oct. DOI: 10.1016/j.arr.2020.101123

• TÍTULO: Blocking IL-1 to prevent respiratory failure in COVID-19.

AUTOR: Frank L van de Veerdonk, Mihai G Netea.
Crit Care. 2020 jul 18. DOI: 10.1186/s13054-020-03166-0

• TÍTULO: Why does COVID‐19 kill more elderly men than women? Is there a role for testosterone?.

AUTOR: Vassilios Papadopoulos, Lu Li, Mary Samplaski.
Andrology. 2020 jul 18. DOI: 10.1111/andr.12868

• TÍTULO: SARS‐CoV‐2 replicating in non‐primate mammalian cells probably have critical advantages for COVID‐19 vaccines due to anti‐Gal antibodies: A minireview and proposals.

AUTOR: Ji-Ming Chen.
J Med Virol. 2020 jul 18. DOI: 10.1002/jmv.26312

• TÍTULO: COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.

AUTOR: Carlo Perricone, Elena Bartoloni, Roberto Bursi…[et all.].
Immunol Res. 2020 jul 17. DOI: 10.1007/s12026-020-09145-5

• TÍTULO: Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation.

AUTOR: Bo Yuan, Han-Qing Liu, Zheng-Rong Yang…[et all.].
Sci Rep. 2020 jul 17. DOI: 10.1038/s41598-020-68782-w

• TÍTULO: SARS-CoV-2 as a Factor to Disbalance the Renin–Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.

AUTOR: Rafael Franco, Rafael Rivas-Santisteban, Joan Serrano-Marín…[et all.].
J Immunol. 2020 jul 17. DOI: 10.4049/jimmunol.2000642

• TÍTULO: ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population.

AUTOR: Elisa Benetti, Rossella Tita, Ottavia Spiga…[et all.].
Eur J Hum Genet. 2020 jul 17. DOI: 10.1038/s41431-020-0691-z

• TÍTULO: Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?.

AUTOR: A Guillon, P S Hiemstra, M Si-Tahar.
Intensive Care Med. 2020 jul 17. DOI: 10.1007/s00134-020-06170-8

• TÍTULO: Could Bordetella pertussis vaccine protect against coronavirus COVID-19?.

AUTOR: Usama M Alkholy, Mohamed E Salama, Hagar Mahmoud, Ahmed Taher, Khaled M Elsayes.
J Glob Antimicrob Resist. 2020 jul 16. DOI: 10.1016/j.jgar.2020.07.005

• TÍTULO: Coagulopathy in COVID-19: Focus on vascular thrombotic events.

AUTOR: Wei Shi, Jiagao Lv, Li Lin.
J Mol Cell Cardiol. 2020 jul 15. DOI: 10.1016/j.yjmcc.2020.07.003

• TÍTULO: Design of a Multi-epitope Vaccine against SARS-CoV-2 using Immunoinformatics approach.

AUTOR: Samira Sanami, Milad Zandi, Behzad Pourhossein…[et all.].
Int J Biol Macromol. 2020 jul 15. DOI: 10.1016/j.ijbiomac.2020.07.117

• TÍTULO: Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes.

AUTOR: Ferdinand Zettl, Toni Luise Meister, Tanja Vollmer…[et all.].
Vaccines (Basel). 2020 jul 15. DOI: 10.3390/vaccines8030386

• TÍTULO: Fish Oil and Covid-19 Thromboses.

AUTOR: Russell J Merritt, Vrinda Bhardwaj, Mohammad M Jami.
J Vasc Surg Venous Lymphat Disord. 2020 jul 15. DOI: 10.1016/j.jvsv.2020.07.002

• TÍTULO: Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (Mpro) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics.

AUTOR: Priyashi Rao, Arpit Shukla, Paritosh Parmar…[et all.].
Biophys Chem. 2020 set. DOI: 10.1016/j.bpc.2020.106425

• TÍTULO: Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan.

AUTOR: Yosuke Hirotsu, Makoto Maejima, Masahiro Shibusawa…[et all.].
J Clin Virol. 2020 aug. DOI: 10.1016/j.jcv.2020.104543

• TÍTULO: ACE2, the Receptor that Enables the Infection by SARS‐CoV‐2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators. 

AUTOR: Gross LZ, Sacerdoti M, Piiper A, Zeuzem S, Leroux AE, Biondi RM.
ChemMedChem. 2020 jul 14. DOI: 10.1002/cmdc.202000368

• TÍTULO: Current status of COVID‐19 (pre)clinical vaccine development.

AUTOR: Bruno de Geest, Tingting Ye, Zifu Zhong, Adolfo García-Sastre, Michael Schotsaert.
Angew Chem Int Ed Engl. 2020 jul 14. DOI: 10.1002/anie.202008319

• TÍTULO: COVID‐19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes. 

AUTOR: Kahinho P Muyayalo, Dong-Hui Huang, Si-Jia Zhao, Ting Xie, Gil Mor, Ai-Hua Liao.
J Reprod Immunol. 2020 julio. DOI: 10.1111/aji.13304

• TÍTULO: Omputer modelling of a potential agent against SARS‐Cov ‐2 (COVID ‐19) protease.

AUTOR: Arthur M Lesk, Arun S Konagurthu, Lloyd Allison…[et all.].
Proteins. 2020 jul 14. DOI: 10.1002/prot.25980

• TÍTULO: Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity. 

AUTOR: Kara L Lynch, Jeffrey D Whitman, Noreen P Lacanienta…[et all.].
Clin Infect Dis. 2020 jul 14. DOI: 10.1093/cid/ciaa979

• TÍTULO: RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery.

AUTOR: Wei Zhu, Catherine Z Chen, Kirill Gorshkov, Miao Xu, Donald C Lo, Wei Zheng.
SLAS Discov. 2020 jul 13. DOI: 10.1177/2472555220942123

• TÍTULO: Hypothetical targets and plausible drugs of Coronavirus infection caused by SARS‐CoV‐2.

AUTOR: Faezeh Almasi, Fatemeh Mohammadipanah.
Transbound Emerg Dis. 2020 jul 13. DOI: 10.1111/tbed.13734

• TÍTULO: Immune-mediated approaches against COVID-19.

AUTOR: Helena F Florindo, Ron Kleiner, Daniella Vaskovich-Koubi…[et all.].
Nat Nanotechnol. 2020 jul 13. DOI: 10.1038/s41565-020-0732-3

• TÍTULO: Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19.

AUTOR: Pinky, Suchi Gupta, Vishnu Krishnakumar…[et all].
Stem Cell Rev Rep. 2020 jul 13. DOI: 10.1007/s12015-020-10002-z

• TÍTULO: Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.

AUTOR: Wentao Ni, Xiuwen Yang, Deqing Yang…[et all.].
Crit Care. 2020 jul 13. DOI: 10.1186/s13054-020-03120-0

• TÍTULO: COVID-19 and purinergic signaling: the need for investigation.

AUTOR: Andréia Machado Cardoso.
Purinergic Signal. 2020 jul 13. DOI: 10.1007/s11302-020-09713-2

• TITULO: Broad and differential animal ACE2 receptor usage by SARS-CoV-2. 

AUTOR: Xuesen Zhao, Danying Chen, Robert Szabla…[et all.].
J Virol. 2020 jul 13. DOI: 10.1128/JVI.00940-20

• TITULO: SARS‐CoV‐2, COVID‐19, skin and immunology ‐ what do we know so far?.

AUTOR: N Novak 1, W M Peng 1, M C Naegeli…[et. all].
Allergy. 2020 jul 13. DOI: 10.1111/all.14498

• TITULO: Proteomics and informatics for understanding phases and identifying biomarkers in COVID-19 disease. 

AUTOR: Anthony D Whetton, George W Preston, Semira Abubeker, Nophar Geifman.
J Proteome Res. 2020 jul 12. DOI: 10.1021/acs.jproteome.0c00326

• TITULO: Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review. 

AUTOR: Jayanta Sarkar, Rajdeep Guha.
Vet Res Commun. 2020 jul 10. DOI: 10.1007/s11259-020-09778-9

• TITULO: Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report. 

AUTOR: Brandon Michael Henry, Stefanie Benoit, Giuseppe Lippi, Justin Benoit.
Prog Cardiovasc Dis. 2020 jul 10. DOI: 10.1016/j.pcad.2020.07.006

• TITULO: Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement. 

AUTOR: Kamran Kadkhoda.
Curr Opin Rheumatol. 2020 jul 09. DOI: 10.1097/BOR.0000000000000728

• TITULO: Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.

AUTOR: Chang Li, Lin Wang, Linzhu Ren.
Virus Res. 2020 jun 24. DOI: 10.1016/j.virusres.2020.198073

• TITULO: The cytokine storm and COVID‐19.

AUTOR: Biying Hu,  Shaoying Huang,  Lianghong Yin.
J Med Virol. 2020 jun 27. DOI: 10.1002/jmv.26232

• TITULO: A role for selenium-dependent GPX1 in SARS-CoV-2 virulence .

AUTOR: Lucia A Seale, Daniel J Torres, Marla J Berry, Matthew W Pitts.
Am J Clin Nutr. 2020 jun 27. DOI: 10.1093/ajcn/nqaa177

• TITULO: Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress síndrome.

AUTOR: Daniela Weiskopf, Katharina S Schmitz, Matthijs P Raadsen…[et all.].
Sci Immunol. 2020 jun 26. DOI: 10.1126/sciimmunol.abd2071

• TITULO: Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells.

AUTOR: Mirza S Baig, Manikandan Alagumuthu, Sajjan Rajpoot, Uzma Saqib.
Drugs R D. 2020 jun 26. DOI: 10.1007/s40268-020-00312-5

• TITULO: A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.

AUTOR: Wafaa B Alsoussi, Jackson S Turner, James B Case…[et all.].
J Immunol. 2020 jun 26. DOI: 10.4049/jimmunol.2000583

• TITULO: The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics.

AUTOR: Marco Siccardi, Jonathan Schapiro, Giovanni Di Perri, David J Back.
J Antimicrob Chemother. 2020 jun 26. DOI: 10.1093/jac/dkaa272

• TITULO: ‘Primed’ Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients.

AUTOR: Syed Shadab Raza, Pankaj Seth, Mohsin Ali Khan.
Stem Cell Rev Rep. 2020 jun 26. DOI: 10.1007/s12015-020-09999-0

• TITULO: Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19).

AUTOR: Jason Kim, Jenny Zhang, Yoonjeong Cha…[et all.].
J Transl Med. 2020 jun 25. DOI: 10.1186/s12967-020-02430-9

• TITULO: Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9.

AUTOR: Dene R Littler, Benjamin S Gully, Rhys N Colson, Jamie Rossjohn.
iScience. 2020 jun 09. DOI: 10.1016/j.isci.2020.101258

• TITULO: The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway..

AUTOR: Jin-Yan Li, Ce-Heng Liao 2, Qiong Wang.
Virus Res. 2020 jun 23. DOI: 10.1016/j.virusres.2020.198074

• TITULO: Data, reagents, assays and merits of proteomics for SARS-CoV-2 research and testing. 

AUTOR: Jana Zecha, Chien-Yun Lee, Florian P Bayer…[et all.].
Mol Cell Proteomics. 2020 jun 26. DOI: 10.1074/mcp.RA120.002164

• TITULO: Comparative analysis of protein synthesis rate in COVID-19 with other human coronaviruses. 

AUTOR: Chandra Mohan Dasari, Raju Bhukya.
Infect Genet Evol. 2020 jun 24. DOI: 10.1016/j.meegid.2020.104432

• TITULO: Methylation Pathways and SARS-CoV-2 Lung Infiltration and Cell Membrane-Virus Fusion Are Both Subject to Epigenetics. 

AUTOR: Leo Pruimboom.
Front Cell Infect Microbiol. 2020 may 26. DOI: 10.3389/fcimb.2020.00290

• TITULO: Autophagy/virophagy: a “disposal strategy” to combat COVID-19.

AUTOR: Dalibor Mijaljica, Daniel J Klionsky.
Autophagy. 2020 jun 24. DOI: 10.1080/15548627.2020.1782022

• TITULO: Platelet Gene Expression and Function in COVID-19 Patients.

AUTOR: Bhanu Kanth Manne, Frederik Denorme, Elizabeth A Middleton…[et all.]
Blood. 2020 jun 23. DOI: 10.1182/blood.2020007214

• TITULO: ACE TMPRSS2 variation in savanna monkeys (Chlorocebus spp.): Potential risk for zoonotic/anthroponotic transmission of SARS-CoV-2 and a potential model for functional studies. 

AUTOR: Christopher A Schmitt, Christina M Bergey, Anna J Jasinska.
PLoS One. 2020 jun 23. DOI: 10.1371/journal.pone.0235106

• TITULO: Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19).

AUTOR: Florian Kurth, Maria Roennefarth, Charlotte Thibeault…[et all.].
Infection. 2020 jun 13. DOI: 10.1007/s15010-020-01464-x

• TITULO: Covid-19 and autoimmunity.

AUTOR: Michael Ehrenfeld, Angela Tincani, Laura Andreoli …[et all.].
Autoimmun Rev. 2020 jun 11. DOI: 10.1016/j.autrev.2020.102597

• TITULO: Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond.

AUTOR: Sumit Kar, Rafiqul Islam.
Commentary | Bioanalysis. 2020 may 26. DOI: 10.4155/bio-2020-0116

• TITULO: SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.

AUTOR: Praveen Anand, Arjun Puranik, Murali Aravamudan, A J Venkatakrishnan, Venky Soundararajan.
Article | Elife. 2020 may 26. DOI: 10.7554/eLife.58603

• TITULO: In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2.

AUTOR: Satyajit Beura, Chetti Prabhakar.
Article |  J Biomol Struct Dyn. 2020 may. DOI: 10.1080/07391102.2020.1772111

• TITULO: Identification of Phytochemical Inhibitors Against Main Protease of COVID-19 Using Molecular Modeling Approaches.

AUTOR: Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla.
Article |  J Biomol Struct Dyn. 2020 may. DOI: 10.1080/07391102.2020.1772112

• TITULO: Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach.

AUTOR: Arun Bahadur Gurung, Mohammad Ajmal Ali, Joongku Lee.
Article |  Life Sci. 2020 may. DOI: 10.1016/j.lfs.2020.117831

• TITULO: A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping.

AUTOR: Maria Romano, Alessia Ruggiero, Flavia Squeglia.
Review |  Cells. 2020 may 20. DOI: 10.3390/cells9051267

• TITULO: Mechanism of Inflammatory Response in Associated Comorbidities in COVID-19.

AUTOR: Thays Maria Costa de Lucena, Ariane Fernandes da Silva Santos, Brenda Regina de Lima, 
Maria Eduarda de Albuquerque Borborema, Jaqueline de Azevêdo Silva.
Article |  Diabetes Metab Syndr. 2020 may. DOI: 10.1016/j.dsx.2020.05.025

• TITULO: COVID-19: CADD to the rescue.

AUTOR: Abdulmujeeb T Onawole, Kazeem O Sulaiman, Temitope U Kolapo…[et all.].
Article |  Virus Res. 2020 may. Abstract. DOI: 10.1016/j.virusres.2020.198022

• TITULO: The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: a sentinel?.

AUTOR: Da-Wei Sun, Dong Zhang, Run-Hui Tian.
Article |  Clin Chim Acta. 2020 may. DOI: 10.1016/j.cca.2020.05.027

• TITULO: Complement activation in patients with COVID-19: a novel therapeutic target.

AUTOR: Massimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti.
Letter |  J Allergy Clin Immunol. 2020 may. DOI: 10.1016/j.jaci.2020.05.006

• TITULO: Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. 

AUTOR: Yi C, Sun X, Ye J…[et all.].  
Article |  Cell Mol Immunol. 2020 may. DOI: 10.1038/s41423-020-0458-z

• TITULO: On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2. 

AUTOR: Giron CC, Laaksonen A, da Silva FLB. 
Article |  Virus Res. 2020 may. DOI: 10.1016/j.virusres.2020.198021

• TITULO: CRISPR-Cas Systems Based Molecular Diagnostic Tool for Infectious Diseases and Emerging 2019 Novel Coronavirus (COVID-19) Pneumonia.

AUTOR: Xiang X, Qian K, Zhang Z, Lin F, Xie Y, Liu Y, Yang Z.
Review |  J Drug Target. 2020 may 13. DOI: 10.1080/1061186X.2020.1769637

• TITULO: Targeting the dimerization of main protease of coronaviruses: A potential broad-spectrum therapeutic strategy.

AUTOR: Goyal B, Goyal D.
Review |  ACS Comb Sci. 2020 may 13. DOI: 10.1021/acscombsci.0c00058

• TITULO: Development of Remdesivir Repositioning as a Nucleotide Analog Against COVID-19 RNA Dependent RNA Polymerase.

AUTOR: Nejadi Babadaei MM, Hasan A, Vahdani Y, Haj Bloukh S, Sharifi M, Kachooei E, Haghighat S, 
Falahati M.
Review |  J Biomol Struct Dyn. 2020 may 13. DOI: 10.1080/07391102.2020.1767210

• TITULO: Respiratory disease in rhesus macaques inoculated with SARS-CoV-2.

AUTOR: Munster VJ, Feldmann F, Williamson BN.
Article |  Nature. 2020 may 12. DOI: 10.1038/s41586-020-2324-7

• TITULO: COVID-19 outcomes and the human genoma.

AUTOR: Murray MF, Kenny EE, Ritchie MD.
Commentary |  Genet Med. 2020 may 11. DOI: 10.1038/s41436-020-0832-3

• TITULO: Truncated human Angiotensin Converting Enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.

AUTOR: Basit A, Ali T, Rehman SU.
Article |  J Biomol Struct Dyn. 2020 may 12. DOI: 10.1080/07391102.2020.1768150

• TITULO: Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19.

AUTOR: Azkur AK, Akdis M, Azkur D.
Review |  Allergy. 2020 may 12. DOI: 10.1111/all.14364

• TITULO: Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations.

AUTOR: Sk MF, Roy R, Jonniya NA, Poddar S. Kar P.
Article |  J Biomol Struct Dyn. 2020 may 11. DOI: 10.1080/07391102.2020.1768149

• TITULO: Covid-19 and co-morbidities: a role for Dipeptidyl Peptidase 4 (DPP4) in disease severity?.

AUTOR: Bassendine MF, Bridge SH, McCaughan GW, Gorrell MD.
Review |  J Diabetes. 2020 may 11. DOI: 10.1111/1753-0407.13052

• TITULO: Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study.

AUTOR: Peele KA, Chandrasai P, Srihansa T.
Short Communication |  Inform Med Unlocked. 2020 may 11. DOI: 10.1016/j.imu.2020.100345

• TITULO: Novel Coronavirus Polymerase and Nucleotidyl-transferase Structures: Potential to Target New Outbreaks.

AUTOR: Zhang W, Stephen P, Thériault JF, Wang R, Lin SX.
Article |  J Phys Chem Lett. 2020 may. DOI: 10.1021/acs.jpclett.0c00571

• TITULO: Computational screening of antagonist against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking.

AUTOR: Yu R, Chen L, Lan R, Shen R, Li P.
Article |  Int J Antimicrob Agents. 2020 may. DOI:  10.1016/j.ijantimicag.2020.106012

• TITULO: COVID-19: unanswered questions on immune response and pathogenesis.

AUTOR: Maggi E, Canonica GW, Moretta L.
Short Survey |  J Allergy Clin Immunol. 2020 may. DOI. 10.1016/j.jaci.2020.05.001

• TITULO: Urgent need for evaluating agonists of Angiotensin-(1-7)/ Mas receptor axis for treatment of patients with COVID-19.

AUTOR: Shete A.
Article |  Int J Infect Dis. 2020 may. DOI: 10.1016/j.ijid.2020.05.002

• TITULO: Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19).

AUTOR: Khodadadi E, Maroufi P, Khodadadi E…[et all.].
Article |  Microb Pathog. 2020 may 05. DOI: 10.1016/j.micpath.2020.104241

• TITULO: Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection.

AUTOR: Barton MC, Bennett KV, Cook JR, Gallup GG Jr, Platek SM.
Article |  Med Hypotheses. 2020 apr 22. DOI: 10.1016/j.mehy.2020.109750

• TITULO: The powerful immune system against powerful COVID-19: A hypothesis.

AUTOR: Taghizadeh-Hesary F, Akbari H.
Article |  Med Hypotheses. 2020 apr 22. DOI: 10.1016/j.mehy.2020.109762

• TITULO: Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.

AUTOR: Hui KPY, Cheung MC, Perera RAPM…[et all.].
Article |  Lancet Respir Med. 2020 may 07. DOI: 10.1016/S2213-2600(20)30193-4

• TITULO: Could CGRP antagonists be helpful in the fight against COVID‐19?

AUTOR: Carrie E. Robertson. 
Vox Clamantis |  Headache. 2020 may 09. DOI: https://doi.org/10.1111/head.13853

• TITULO: HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19.

AUTOR: Francesca Romana Spinelli, Fabrizio Conti, Massimo Gadina. 
Focus |  Sci Immunol. 2020 may 08. DOI: 10.1126/sciimmunol.abc5367

• TITULO: Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).

AUTOR: Neil Mehta, Ankur Kalra, Amy S. Nowacki…[et all.].
Article |  JAMA Cardiol. 2020 may 05. DOI: 10.1001/jamacardio.2020.1855

• TITULO: ANNALS EXPRESS: Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: a closer look at angiotensin-converting enzyme 2 (ACE2).

AUTOR: Annalise E. Zemlin, Owen J Wiese.
Article |  Ann Clin Biochem. 2020 may 05. DOI: https://doi.org/10.1177/0004563220928361

• TITULO: Potential Inhibitors of Coronavirus 3-Chymotrypsin-Like Protease (3CLpro): An in silico screening of Alkaloids and Terpenoids from African medicinal plants.

AUTOR: Gideon A. Gyebi, Olalekan B. Ogunro, Adegbenro P. Adegunloye, Oludare M. Ogunyemi, 
Saheed O. Afolabi.
Article |  J Biomol Struct Dyn. 2020 may 05. DOI: https://doi.org/10.1080/07391102.2020.1764868

• TITULO: A human monoclonal antibody blocking SARS-CoV-2 infection.

AUTOR: Chunyan Wang, Wentao Li, Dubravka Drabek, Nisreen M. A. Okba…[et all.].
Article |  Nat Commun. 2020 may 04. DOI: https://doi.org/10.1038/s41467-020-16256-y

• TITULO: Site-specific glycan analysis of the SARS-CoV-2 spike.

AUTOR: Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin.
Report |  SCIENCE. 2020 may 04. DOI: 10.1126/science.abb9983

• TITULO: The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor.

AUTOR: Esther S. Brielle, Dina Schneidman-Duhovny, Michal Linial.
Article |  Viruses. 2020 april 30. DOI: https://doi.org/10.3390/v12050497

• TITULO: Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes.

AUTOR: Maddalena Dilucca, Sergio Forcelloni, Alexandros G. Georgakilas.
Article |  Viruses. 2020 april 30. DOI: https://doi.org/10.3390/v12050498

• TITULO: Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019.

AUTOR: Yong-Jian Geng, Zhi-Yao Wei, Hai-Yan Qian, Ji Huang, Robert Lodato, Richard J.Castriotta.
Review |  Cardiovasc Pathol. 2020 july. DOI: https://doi.org/10.1016/j.carpath.2020.107228

• TITULO: Potential anti‐SARS‐CoV‐2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease.

AUTOR: Motonori Tsuji.
Article |  FEBS Open Bio. 2020 may 06. DOI: https://doi.org/10.1002/2211-5463.12875

• TITULO: Expression of the COVID‐19 receptor ACE2 in the human conjunctiva.

AUTOR: Clemens Lange, Julian Wolf, Claudia Auw‐Haedrich…[et all].
Article |  J Med Virol. 2020 may 06. DOI: https://doi.org/10.1002/jmv.25981

• TITULO: COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak.

AUTOR: Abdul Arif Khan, Zakir Khan.
Article |  Bioinformatics. 2020 may 06. DOI: https://doi.org/10.1093/bioinformatics/btaa285

• TITULO: The anti‐HIV Drug Nelfinavir Mesylate (Viracept) is a Potent Inhibitor of Cell Fusion Caused by the SARS‐CoV‐2 Spike (S) Glycoprotein Warranting further Evaluation as an Antiviral against COVID‐19 infections.

AUTOR: Farhana Musarrat, Vladimir Chouljenko, Achyut Dahal.
Article |  J Med Virol. 2020 may 06. DOI: https://doi.org/10.1002/jmv.25985

• TITULO: Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?.

AUTOR: Fabio Perrotta, Maria Gabriella Matera, Mario Cazzola, Andrea Bianco.
Review |  Respir Med. 2020 april 25. DOI: https://doi.org/10.1016/j.rmed.2020.105996

• TITULO: Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperaturas.

AUTOR: Durgesh Kumar, Kamlesh Kumari, Abhilash Jayaraj, Vinod Kumar, Ramappa Venkatesh Kumar, 
Sujata K. Dass.
Express Communication |  J Biomol Struct Dyn. 2020  may 04. DOI: https://doi.org/10.1080/07391
102.2020.1752310

• TITULO: Potential influence of COVID-19/ACE2 on the female reproductive system.

AUTOR: Yan Jing, Li Run-Qian, Wang Hao-Ran, Chen Hao-Ran, Liu Ya-Bin, Gao Yang. 
Article |  Mol Hum Reprod. 2020 may 04. DOI: https://doi.org/10.1093/molehr/gaaa030

• TITULO: Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2.

AUTOR: Asif Shajahan, Nitin T Supekar, Anne S Gleinich, Parastoo Azadi. 
Article |  Glycobiology. 2020 may 04. DOI: https://doi.org/10.1093/glycob/cwaa042

• TITULO: Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform.

AUTOR: Tran Thi Nhu Thao, Fabien Labroussaa…[et all.]. 
Article |  Nature. 2020 may 04. DOI: https://doi.org/10.1038/s41586-020-2294-9

• TITULO: An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study.

AUTOR: Sourav Das, Sharat Sarmah, Sona Lyndem, Atanu Singha Roy. 
Article |  J Biomol Struct Dyn. 2020 may 02. DOI: https://doi.org/10.1080/07391102.2020.1763201

• TITULO: Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.

AUTOR: Zhixian Yao, Zhong Zheng, Ke Wu, Zheng Junhua. 
Article |  Aging. 2020 may 02. DOI: https://doi.org/10.18632/aging.103101

• TITULO: Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.

AUTOR: Umesh, Debanjan Kundu, Chandrabose Selvaraj, Sanjeev Kumar Singh, Vikash Kumar Dubey. 
Article |  J Biomol Struct Dyn. 2020 may 02. DOI: https://doi.org/10.1080/07391102.2020.1763202

• TITULO: Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock.

AUTOR: Dipti Mothay, K. V. Ramesh. 
Article |  Virusdisease. 2020 may 02. DOI: https://doi.org/10.1007/s13337-020-00585-z

• TITULO: In silico study the inhibition of Angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from western Algeria.

AUTOR: Imane Abdelli, Faiçal Hassani, Sohayb Bekkel Brikci, Said Ghalem. 
Article |  J Biomol Struct Dyn. 2020 may 02. DOI: https://doi.org/10.1080/07391102.2020.1763199

• TITULO: A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.

AUTOR: Markus Hoffmann, annah Kleine-Weber, Stefan Pöhlmann. 
Short Article |  Mol Cell. 2020 may 01. DOI: https://doi.org/10.1016/j.molcel.2020.04.022

• TITULO: A Dynamic Immune Response Shapes COVID-19 Progression.

AUTOR: Eugenia Ziying Ong, Yvonne Fu Zi Chan, Wan Ying Leong…[et all.]. 
Brief Article |  Cell Host Microbe. 2020 april 30. DOI: https://doi.org/10.1016/j.chom.2020.03.
021

• TITULO: Baculovirus transit through insect cell membranes: A mechanistic approach.

AUTOR: Youhong Zhanga, Giora Enden, Wei Wei…[et al.]. 
Article |  Chem Eng Sci. 2020. April 25. Abstract. DOI: https://doi.org/10.1016/j.ces.2020.115727

• TITULO: Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites.

AUTOR: Sisi Kan, Mei Yang, Zhongsi Hong, Liping Zhang…[et all.]. 
Article |  Acta Pharm Sin B. 2020 april 20. DOI: https://doi.org/10.1016/j.apsb.2020.04.009

• TITULO: Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19.

AUTOR: Junaid Kashir, Ahmed Yaqinuddin.
Article |  Med. Hypotheses. 2020 august. DOI: https://doi.org/10.1016/j.mehy.2020.109786

• TITULO: New understanding of the damage of SARS-CoV-2 infection outside the respiratory system.

AUTOR: Yuhao Zhang, Xiuchao Geng, Yanli Tan, Qiang Li, Can Xu, Jianglong Xu, Liangchao Hao. [et all.].
Review |  Biomed Pharmacother. 2020 july. DOI: https://doi.org/10.1016/j.biopha.2020.110195

• TITULO: A hypothesized role for dysregulated bradykinin signaling in COVID‐19 respiratory complications.

AUTOR: Joseph A. Roche, Renuka Roche. 
Hypotheses |  FASEB J. 2020 may 02. DOI: https://doi.org/10.1096/fj.202000967

• TITULO: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China.

AUTOR: Jing Lu, Louis du Plessis, Zhe Liu…[et all.]. 
Article |  Cell. 2020 april 30. DOI: https://doi.org/10.1016/j.cell.2020.04.023

• TITULO: Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.

AUTOR: Wanchao Yin, Chunyou Mao, Xiaodong Luan…[et al.].
Report |  Science. 2020 may 01. DOI: 10.1126/science.abc1560

• TITULO: SARS-CoV-2 productively infects human gut enterocytes.

AUTOR: Mart M. Lamers, Joep Beumer, Jelte van der Vaart…[et al.].
Article |  Science. 2020 may 01. DOI: 10.1126/science.abc1669

• TITULO: Mathematical Modeling of Interaction between Innate and Adaptive Immune Responses in COVID‐19 and Implications for Viral Pathogenesis.

AUTOR: Sean Quan Du, Weiming Yuan. 
Article |  J Med Virol. 2020 may 01. DOI: https://doi.org/10.1002/jmv.25866

• TITULO: Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19.

AUTOR: Harmony R. Reynolds, Samrachana Adhikari, Claudia Pulgarin…[et al.]. 
Article |  N Engl J Med. 2020 may 01. DOI: 10.1056/NEJMoa2008975

• TITULO: Impaired interferon signature in severe COVID-19.

AUTOR:Conor Gruber. 
In Brief |  Nat Rev Immunol. 2020 april 30. DOI: https://doi.org/10.1038/s41577-020-0335-0

• TITULO: Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management.

AUTOR: Jingwei Zhang, Baback Gharizadeh, Daru Lu, Junqiu Yue…[et al.]. 
Article |  IEEE Rev Biomed Eng. 2020 april 29. DOI: 10.1109/RBME.2020.2991444

• TITULO: ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?.

AUTOR: Li Xiao, Hiroshi Sakagami, Nobuhiko Miwa. 
Commentary |  Viruses. 2020 april 28. DOI: https://doi.org/10.3390/v12050491

• TITULO: IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study.

AUTOR:  Andrea Padoan, Laura Sciacovelli, Daniela Basso…[et al.].
Short Communication |  Clin Chim Acta. 2020 august. Abstract. 
DOI: https://doi.org/10.1016/j.cca.2020.04.026

• TITULO: A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: Potential implications for the SARS-CoV-2 modus operandi.

AUTOR:  George D. Vavougios.
Article |  Med. Hypotheses. 2020 july. DOI: https://doi.org/10.1016/j.mehy.2020.109759

• TITULO: Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents.

AUTOR:  Ahmed Yaqinuddin, Junaid Kashir. 
Article |  Med. Hypotheses. 2020 july. DOI: https://doi.org/10.1016/j.mehy.2020.109777

• TITULO: SARS-CoV-2 Serology: Much Hype, Little Data.

AUTOR:  Christopher W Farnsworth, Neil W Anderson. 
Opinion |  Clin Chem. 2020 april 28. DOI: https://doi.org/10.1093/clinchem/hvaa107

• TITULO: Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens.

AUTOR:  Wei Zhen, Ryhana Manji, Elizabeth Smith, Gregory J. Berry. 
Article |  J Clin Microbiol. 2020 april 27. DOI: 10.1128/JCM.00743-20

• TITULO: Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19.

AUTOR:  Hisashi Kai, Mamiko Kai. 
Review |  Hypertens Res. 2020 april 27. DOI: https://doi.org/10.1038/s41440-020-0455-8

• TITULO: The role of natriuretic peptide estimation in severe COVID-19.

AUTOR:  Kunal Mahajan. Monaldi 
Perspective |  Arch Chest Dis. 2020 april 27.DOI: https://doi.org/10.4081/monaldi.2020.1316

• TITULO: Natural products may interfere with SARS-CoV-2 attachment to the host cell.

AUTOR:  Abdo A Elfiky.
Article |  J Biomol Struct Dyn. 2020 april 27. DOI: https://doi.org/10.1080/07391102.2020.1761881

• TITULO: Nanoscale nights of COVID-19.

AUTOR: Kostas Kostarelos. 
Thesis |  Nat Nanotechnol. 2020 april 27. DOI: https://doi.org/10.1038/s41565-020-0687-4

• TITULO: Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.

AUTOR: Davide Gentile, Vincenzo Patamia, Angela Scala..[et al.]. 
Article |  Mar Drugs. 2020 april 24. DOI: https://doi.org/10.3390/md18040225

• TITULO: COVID-19: Disease, management, treatment, and social impact.

AUTOR: Imran Ali, Omar M.L. Alharbi. 
Review |  Sci Total Environ. 2020 april august. DOI: https://doi.org/10.1016/j.scitotenv.2020.
138861

• TITULO:  Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation.

AUTOR:  Flavio Dormont, Romain Brusini, Catherine Cailleau…[et al.].
Article |  Sci. Adv. 2020 april 27. DOI: 10.1126/sciadv.aaz5466

• TITULO:  Trained immunity: a tool for reducing susceptibility and severity of SARS-CoV2 infection.

AUTOR:  Mihai G. Netea1,2,*, Evangelos J. Giamarellos-Bourboulis…[et al.].
Article |  Cellpres. 2020 DOI: DOI: 10.1016/j.cell.2020.04.042

• TITULO: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.

AUTOR: Indwiani Astuti, Ysrafil.
Article |  Diabetes Metab Syndr. 2020 july-august. DOI: https://doi.org/10.1016/j.dsx.2020.04.020

• TITULO: Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis.

AUTOR: Erkan Cure, Medine Cumhur Cure.
Article |  Diabetes Metab Syndr. 2020 july-august. DOI:  https://doi.org/10.1016/j.dsx.2020.04.024

• TITULO: DPP4 inhibition: preventing SARS‐CoV‐2 infection and/or progression of COVID‐19?.

AUTOR: Rocky Strollo, Paolo Pozzilli.
Commentary |  Diabetes Metab Res Rev. 2020 april 26. DOI: https://doi.org/10.1002/dmrr.3330

• TITULO: In the search of potential epitopes for Wuhan seafood market pneumonia virus using high order nullomers.

AUTOR: Daniele Santoni, Davide Vergni.
Technical Note  |  J Immunol Methods. 2020 april 23. DOI: https://doi.org/10.1016/j.jim.2020.11278

• TITULO: Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratorios.

AUTOR: Takayuki Ishige, Shota Murata, Toshibumi Taniguchi…[et.al.].
Article |  Clin Chim Acta. 2020 april 23. DOI: 10.1016/j.cca.2020.04.023

• TITULO: Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover.

AUTOR: Annarosa Soresina,  Daniele Moratto,  Marco Chiarini…[et al.].
Article |  Pediatr Allergy Immunol. 2020 april 22. DOI: https://doi.org/10.1111/pai.13263

• TITULO: Understanding evolution of SARS‐CoV‐2: a perspective from analysis of genetic diversity of RdRp gene

AUTOR: Sunitha M. Kasibhatla, Meenal Kinikar, Sanket Limaye…[et al.].
Article |  J Med Virol . 2020. April 21. DOI: https://doi.org/10.1002/jmv.25909

• TITULO: Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2.

AUTOR: Yun Hee Baek, Jihye Um, Khristine Joy C. Antigua…[et.al.].
Journal Emerging Microbes & Infection. 2020 april 20. 
DOI: https://doi.org/10.1080/22221751.2020.1756698

• TITULO: Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in COVID-19.

AUTOR: Grace Lui, Lowell Ling, Christopher KC Lai…[et.al.].
Letter  |  Journal of Infection. 2020 april 13. DOI: https://doi.org/10.1016/j.jinf.2020.04.014

• TITULO: Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.

AUTOR: Bo XUa, Cun-yu FANa, An-lu WANG…
Article | Journal of Infection. 2020 april 13. DOI: https://doi.org/10.1016/j.jinf.2020.04.012

• TITULO: Investigating hypothiocyanite against SARS-CoV-2.

AUTOR: L. Cegolon.
Short communication | International Journal of Hygiene and Environmental Health. 2020 june. 
DOI: https://doi.org/10.1016/j.ijheh.2020.113520

• TITULO: COVID-19 A map of SARS-CoV-2 and host cell interactions.

AUTOR: Louise Malle.
In Brief | Nature Reviews Immunology. 2020 april 17. https://doi.org/10.1038/s41577-020-0318-1.

• TITULO: Antibody Detection and Dynamic Characteristics in Patients with COVID-19.

AUTOR: Fei Xiang, Xiaorong Wang, Xinliang He…[et.al.].
Article |  Clinical Infectious Diseases. 2020 april 19. DOI: https://doi.org/10.1093/cid/ciaa461

• TITULO: Cytokine release syndrome in severe COVID-19.

AUTOR: John B. Moore, Carl H. June.
Perspective  |  Science. 2020 april 17. DOI: 10.1126/science.abb8925

• TITULO: SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment.

AUTOR: di Mauro Gabriella, Scavone Cristina, Rafaniello Concetta, Rossi Francesco, Capuano Annalisa.
Short Communication | International Immunopharmacology. 2020 july. 
DOI: https://doi.org/10.1016/j.intimp.2020.106519

• TITULO: Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.

AUTOR: Barry Rockx, Thijs Kuiken, Sander Herfst, Theo Bestebroer…[et.al.].
Report | Science. 2020 april 17. DOI: 10.1126/science.abb7314

• TITULO: Harnessing CAR T Cell Insights to Develop Treatments for Hyperinflammatory Responses in COVID-19 patients.

AUTOR: Sangya Agarwal, Carl H. June.
Cancer Discovery. 2020 april 17. DOI: 10.1158/2159-8290.CD-20-0473

• TITULO: Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients.

AUTOR: Xiaohua Chen, Binghong Zhao…[et. al.].
Article | Clinical Infectious Diseases. 2020 april 17. DOI: https://doi.org/10.1093/cid/ciaa449

• TITULO: Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays.

AUTOR: Guiseppe Lippi, Gian Luca Salvagno…[et. al.].
Letter | Clinical Chemistry and Laboratory Medicine. 2020 april 16. 
DOI: https://doi.org/10.1515/cclm-2020-0473

• TITULO: Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics.

AUTOR: Andrea Padoan, Chiara Cosma…[et. al.].
Article | Clinical Chemistry and Laboratory Medicine. 2020 april 16. 
DOI: https://doi.org/10.1515/cclm-2020-0443

• TITULO: Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses.

AUTOR: Bruno Tilocca…[et. al.].
Article | Microbes and Infection. 2020 april 14. 
DOI: https://doi.org/10.1016/j.micinf.2020.04.002

 

Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense

 

 

Cardiovascular molecular mechanisms of disease with COVID-19

 

 

Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus

 

 

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

 

 

Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2

 

 

Inhibitors of the renin–angiotensin system: The potential role in the pathogenesis of COVID-19

 

 

scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells

 

 

Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection

 

 

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

 

 

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro

 

 

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

 

 

Structural Variations in Human ACE2 may Influence its Binding with SARS‐CoV‐2 Spike Protein

 

 

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

 

 

A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV

 

 

Master Regulator Analysis of the SARS-CoV-2/Human Interactome

 

 

Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2

 

 

Virology, Epidemiology, Pathogenesis, and Control of COVID-19

 

 

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

 

 

Structural basis of receptor recognition by SARS-CoV-2

 

 

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

 

 

A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019‐nCoV)

 

 

COVID-19 spike-host cell receptor GRP78 binding site prediction

 

 

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

 

 

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.

 

 

Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan

 

 

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

 

 

Coronaviruses: An Overview of Their Replication and Pathogenesis

 

 

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

 

 

Is COVID-19 Receiving ADE From Other Coronaviruses?

 

 

RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak

 

 

Evolutionary Perspectives on Novel Coronaviruses Identified in Pneumonia Cases in China

 

 

A precision medicine approach to managing Wuhan Coronavirus pneumonia

 

 

Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target

 

 

Homology Models of Coronavirus 2019-nCoV 3CLpro Protease

 

 

Homology Models of the Papain-Like Protease PLpro from Coronavirus 2019-nCoV

 

 

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhana 

 

 

An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies

 

 

Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination even

 

 

The 2019-newcoronavirusepidemic: evidence for virus evolution

 

 

Coronavirus Infections and Immune Responses

 

 

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

 

 

Coronaviruses: Genome Structure, Replication, and Pathogenesis

 

 

Homologous recombination within the spike glycoprotein of the newly identified coronavirus 2019-nCoV may boost cross-species transmission from snake to human